NO894811L - Vandig doxorubicinloesning. - Google Patents
Vandig doxorubicinloesning.Info
- Publication number
- NO894811L NO894811L NO89894811A NO894811A NO894811L NO 894811 L NO894811 L NO 894811L NO 89894811 A NO89894811 A NO 89894811A NO 894811 A NO894811 A NO 894811A NO 894811 L NO894811 L NO 894811L
- Authority
- NO
- Norway
- Prior art keywords
- solution
- doxorubic
- doxorubicin
- physiologically acceptable
- solutions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
- Lubricants (AREA)
- Lubrication Of Internal Combustion Engines (AREA)
- Steroid Compounds (AREA)
Abstract
Det fremstilles stabile, klar-til-bruk vandige løsninger av doxorubicin inneholdende et fysiologisk akseptabelt salt av doxorubicin, natriumacetonbisulfitt som antioksidant, vann og, om nødvendig en tilstrekkelig mengde av en fysiologisk akseptabel syre eller base til justering av løsningens pH-verdi til innenfor et område på ca. 2,5 til ca. 6,0. Løsningene har en akseptabel lagertid på mere enn 3 år ved 4°C.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27962788A | 1988-12-05 | 1988-12-05 |
Publications (2)
Publication Number | Publication Date |
---|---|
NO894811D0 NO894811D0 (no) | 1989-12-01 |
NO894811L true NO894811L (no) | 1990-06-06 |
Family
ID=23069771
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO89894811A NO894811L (no) | 1988-12-05 | 1989-12-01 | Vandig doxorubicinloesning. |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP0372888B1 (no) |
JP (1) | JPH02200637A (no) |
KR (1) | KR920001460B1 (no) |
AT (1) | ATE78402T1 (no) |
AU (1) | AU612916B2 (no) |
DD (1) | DD295990A5 (no) |
DE (1) | DE68902223T2 (no) |
DK (1) | DK609889A (no) |
ES (1) | ES2044148T3 (no) |
FI (1) | FI895733A0 (no) |
GR (1) | GR3005391T3 (no) |
HU (1) | HU204704B (no) |
IE (1) | IE893867L (no) |
IL (1) | IL92541A0 (no) |
NO (1) | NO894811L (no) |
NZ (1) | NZ231602A (no) |
OA (1) | OA09898A (no) |
PT (1) | PT92483B (no) |
YU (1) | YU226189A (no) |
ZA (1) | ZA899248B (no) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2006213440A1 (en) * | 2005-02-11 | 2006-08-17 | Dabur Pharma Limited | Stabilized anthracycline glycoside pharmaceutical compositions |
US11213538B2 (en) | 2016-02-16 | 2022-01-04 | General Incorporated Association Pharma Valley Project Supporting Organization | Agent for overcoming immunosuppression and use thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8519452D0 (en) * | 1985-08-02 | 1985-09-11 | Erba Farmitalia | Injectable solutions |
FI883338A (fi) * | 1987-07-16 | 1989-01-17 | Bristol Myers Co | Vattenloesningar av doxorubicinhydroklorid. |
-
1989
- 1989-11-30 FI FI895733A patent/FI895733A0/fi not_active Application Discontinuation
- 1989-12-01 NO NO89894811A patent/NO894811L/no unknown
- 1989-12-01 NZ NZ231602A patent/NZ231602A/en unknown
- 1989-12-04 AT AT89312625T patent/ATE78402T1/de not_active IP Right Cessation
- 1989-12-04 ZA ZA899248A patent/ZA899248B/xx unknown
- 1989-12-04 IL IL92541A patent/IL92541A0/xx unknown
- 1989-12-04 EP EP89312625A patent/EP0372888B1/en not_active Expired - Lifetime
- 1989-12-04 PT PT92483A patent/PT92483B/pt not_active IP Right Cessation
- 1989-12-04 DK DK609889A patent/DK609889A/da not_active Application Discontinuation
- 1989-12-04 DE DE8989312625T patent/DE68902223T2/de not_active Expired - Fee Related
- 1989-12-04 ES ES89312625T patent/ES2044148T3/es not_active Expired - Lifetime
- 1989-12-04 IE IE893867A patent/IE893867L/xx unknown
- 1989-12-04 JP JP1315123A patent/JPH02200637A/ja active Pending
- 1989-12-04 KR KR1019890017864A patent/KR920001460B1/ko active Pre-grant Review Request
- 1989-12-04 YU YU02261/89A patent/YU226189A/xx unknown
- 1989-12-04 OA OA59689A patent/OA09898A/fr unknown
- 1989-12-05 AU AU45915/89A patent/AU612916B2/en not_active Ceased
- 1989-12-05 HU HU896426A patent/HU204704B/hu not_active IP Right Cessation
- 1989-12-05 DD DD89335266A patent/DD295990A5/de not_active IP Right Cessation
-
1992
- 1992-08-10 GR GR920400652T patent/GR3005391T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
PT92483A (pt) | 1990-06-29 |
JPH02200637A (ja) | 1990-08-08 |
DK609889A (da) | 1990-06-06 |
PT92483B (pt) | 1995-08-09 |
GR3005391T3 (no) | 1993-05-24 |
ATE78402T1 (de) | 1992-08-15 |
EP0372888A1 (en) | 1990-06-13 |
HU204704B (en) | 1992-02-28 |
HU896426D0 (en) | 1990-02-28 |
EP0372888B1 (en) | 1992-07-22 |
IE893867L (en) | 1990-06-05 |
OA09898A (fr) | 1994-09-15 |
NZ231602A (en) | 1991-12-23 |
FI895733A0 (fi) | 1989-11-30 |
DD295990A5 (de) | 1991-11-21 |
AU4591589A (en) | 1990-06-07 |
DK609889D0 (da) | 1989-12-04 |
KR920001460B1 (ko) | 1992-02-14 |
YU226189A (en) | 1991-02-28 |
DE68902223T2 (de) | 1993-01-14 |
ES2044148T3 (es) | 1994-01-01 |
ZA899248B (en) | 1990-08-29 |
AU612916B2 (en) | 1991-07-18 |
NO894811D0 (no) | 1989-12-01 |
IL92541A0 (en) | 1990-08-31 |
KR900009081A (ko) | 1990-07-02 |
HUT52961A (en) | 1990-09-28 |
DE68902223D1 (de) | 1992-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE8402551L (sv) | Cinnamoylmoranolin-derivat | |
NO863061D0 (no) | Fremgangsmaate for fremstilling av fysiologisk aktive fenoksyeddiksyrederivater. | |
IT1200589B (it) | Derivati naturali attivita farmagologica | |
DK0490549T3 (da) | Stabilisering af calcitonin-holdige farmaceutiske præparater | |
ES2033379T3 (es) | Soluciones acuosas de clorhidrato de doxorubicina. | |
SE9102604D0 (sv) | Farmaceutiska kompositioner innehaallande furanderivat | |
NO894811L (no) | Vandig doxorubicinloesning. | |
ATE93731T1 (de) | Protein enthaltende waesserige loesungen. | |
ATE87210T1 (de) | Doxorubicin-loesungen. | |
ES8705866A1 (es) | Procedimiento de preparar sales fungicidas | |
DK214884A (da) | Chlorphenoxyacetatderivat |